PPARGC1A and metabolic dysfunction-associated steatotic liver disease: Liver: ICA regulates the AMPK/PGC-1α/GLUT4 axis, enhances fatty acid oxidation, and attenuates oxidative stress, demonstrating potential in the treatment of non-alcoholic fatty liver disease (NAFLD).